Present in over 60 countries, UPSA promotes the “Made in France” label around the world. Driven by our strategic plan “Conquest 2027,” we are accelerating our international expansion by strengthening our historical presence in Europe and Africa, while also entering new markets such as China and Saudi Arabia. All of this is managed from Agen (Lot-et-Garonne, France), from where nearly 60% of our production is exported!
Our international expansion
From local to global
We have chosen France as our platform for international growth. Everything starts in Agen (Lot-et-Garonne, France), where 100% of our medicines are manufactured before being distributed to more than 60 countries. UPSA operates a site of over 10,000 m² dedicated to the complex logistics of export markets, with a storage capacity of 11,000 pallets. The site even includes a printing facility to produce leaflets in foreign languages!
From there, our medicines are distributed worldwide through our six subsidiaries (Belgium, Switzerland, Italy, Spain, the United Kingdom, and China), employing more than 70 team members who work to expand our product portfolio, or through certified distributors. In short, it’s a precisely coordinated operation!
. Everything starts in Agen (Lot-et-Garonne, France), where 100% of our medicines are manufactured before being distributed to nearly 70 countries. UPSA operates a site of over 10,000 m² dedicated to the complex logistics of export markets, with a storage capacity of 11,000 pallets. The site even includes a printing facility to produce leaflets in foreign languages!
From there, our medicines are distributed worldwide through our six subsidiaries (Belgium, Switzerland, Italy, Spain, the United Kingdom, and China), employing more than 70 team members who work to expand our product portfolio, or through certified distributors. In short, it’s a precisely coordinated operation!
World, here we come!
With 55% of our total revenue coming from exports, international sales represent a major part of our competitiveness. UPSA is experiencing strong growth in its key markets across Europe (Belgium, Switzerland, Greece, and Spain), French-speaking Africa, and Vietnam. And we are continuing this momentum by expanding into new territories.
Since 2023, UPSA has been offering its food supplements on Tmall, the leading e-commerce platform in China. In 2024, we successfully entered the Middle East through Saudi Arabia and English-speaking Africa through Kenya. This acceleration has begun with the acquisition of Sérélys Pharma, present in over 50 countries, particularly in the Middle East, North and South America. We will be able to offer women sustainable solutions for their health and well-being.
“Made in France”: our four-leaf clover advantage
Our international strategy is driven by our commitment to “Made in France.” It’s not just a belief,
it’s a strength across many markets, a mark of French excellence. Beyond that, we are proud that a mid-sized company like UPSA can contribute to France’s trade balance and promote French expertise around the world. It’s a great way to showcase the appeal of the French pharmaceutical industry!
